Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.phrs.2022.106524
10.1016/j.phrs.2022.106524 · External reference
10.1016/j.ekir.2023.01.034
10.1016/j.ekir.2023.01.034 · External reference
10.1016/j.jjcc.2016.10.019
10.1016/j.jjcc.2016.10.019 · External reference
10.1007/s13340-019-00415-8
10.1007/s13340-019-00415-8 · External reference
10.1056/nejmoa1811744
10.1056/nejmoa1811744 · External reference
10.1056/nejmoa1515920
10.1056/nejmoa1515920 · External reference
10.1007/s13340-020-00471-5
10.1007/s13340-020-00471-5 · External reference
10.1001/jamacardio.2020.4511
10.1001/jamacardio.2020.4511 · External reference
10.1111/jdi.13960
10.1111/jdi.13960 · External reference
10.1111/dom.15472
10.1111/dom.15472 · External reference
10.1136/bmjopen-2024-084526
10.1136/bmjopen-2024-084526 · External reference
10.1016/j.jcjd.2021.12.005
10.1016/j.jcjd.2021.12.005 · External reference
10.1507/endocrj.ej23-0317
10.1507/endocrj.ej23-0317 · External reference
10.7326/m18-3136
10.7326/m18-3136 · External reference
10.1186/s12879-021-06735-y
10.1186/s12879-021-06735-y · External reference
10.1111/jdi.13636
10.1111/jdi.13636 · External reference
Trends in diabetes medication prescriptions: A 10‐year review by specialists
2022 · External reference
10.1186/s13098-019-0486-y
10.1186/s13098-019-0486-y · External reference
Prevalence of non‐communicable diseases in Japan using a newly developed administrative claims database covering young, middle‐aged, and elderly individuals
2022 · External reference
Unresolved reference
External reference
10.1007/s10384-022-00969-2
10.1007/s10384-022-00969-2 · External reference
10.1007/s13300-023-01421-5
10.1007/s13300-023-01421-5 · External reference
10.1038/s41440-022-00961-w
10.1038/s41440-022-00961-w · External reference
10.1111/dom.14261
10.1111/dom.14261 · External reference
10.2337/dc20-1464
10.2337/dc20-1464 · External reference
10.1253/circrep.cr-21-0004
10.1253/circrep.cr-21-0004 · External reference
10.1001/jama.2024.27402
10.1001/jama.2024.27402 · External reference
10.1007/s13340‐025‐00857‐3
10.1007/s13340‐025‐00857‐3 · External reference
10.3390/jcm12226993
10.3390/jcm12226993 · External reference
Urinary tract infections in the patients with SGLT2 inhibitor
2016 · External reference
10.1111/dom.12428
10.1111/dom.12428 · External reference
Precautions for the treatment of urinary tract infections in diabetic patients: Key features, emphysematous urinary tract infections, and the impact of SGLT2 inhibitors
2023 · External reference
Unresolved reference
External reference
10.1536/ihj.54.93
10.1536/ihj.54.93 · External reference
10.1007/s40264-013-0068-0
10.1007/s40264-013-0068-0 · External reference
10.1111/dom.13531
10.1111/dom.13531 · External reference
10.1007/s12325-021-01759-x
10.1007/s12325-021-01759-x · External reference
